---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-017283"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2025-07-01T23:59:59+00:00"
generated_at: "2026-05-18T10:32:02.065437+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Indaptus raises additional $3.4M via convertible notes and warrants, total $5.7M

## Summary
- Second closing of private placement adds $3.4M in convertible notes; aggregate gross proceeds now $5.7M.
- Notes bear 6% interest, mature July 28, 2026; convert at 80% of 5-day VWAP (max $11.20).
- Warrants for 200% of conversion shares, 5-year term, exercise price equal to the conversion price.
- Net proceeds to fund Phase 1b/2 clinical trial, R&D, and working capital.
- Paulson Investment Company served as exclusive placement agent.

## SEC filing metadata
- accession: 0001641172-25-017283
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2025-07-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/0001641172-25-017283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000164117225017283/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-017283
- JSON: https://secwatch.observer/filing/0001641172-25-017283.json
- Plain text: https://secwatch.observer/filing/0001641172-25-017283.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.